en · de · es · fr · pt
cjc-1295-notes.peptides6908.com › Data › Background And Molecular Design — Beginner to Advanced

Background And Molecular Design — Beginner to Advanced

By Editorial Desk · published 2026-01-21 · last reviewed 2026-02-23 · Data

GHRH receptor raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

Reviewed 2026-02-23. Anything still debated is marked as such rather than presented as settled.

Background and Molecular Design

CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.

Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.

The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.

Mechanism and Pharmacokinetics

Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.

The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.

Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.

Cjc-1295 at a glance

PropertyValueNotes
Target receptorGHRH receptor (GHRHR)Expressed on pituitary somatotrophs
Primary actionStimulates growth hormone releaseAmplifies pulse size
Half-life, albumin-binding formSeveral days as reportedSlow release from albumin complex
Half-life, unmodified analogAbout 30 minutes in animal estimatesCleared by proteases and filtration
Common analytical approachLC-MS/MS for peptide, immunoassay for hormonesMethods answer different questions

Receptor Action and Clearance

Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.

Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.

Related pages on this site

Structure And Receptor Pharmacology

Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.

Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.

Further detail

Referees, judges, football directors and chairmen were also involved in the scandal, but all defendants deny charges. Olympiakos were the champions of the Greek Super League at the time. 2015 FIFA corruption case 2015 Italian football match-fixing scandal 2016 United Kingdom football sexual abuse scandal 2017 Rangers Tax Fraud Case. The Supreme court ruled that money paid to players, managers and directors between 2001 and 2010 was in the form of tax free loans. This totalled £47m 2018 Football Leaks - Der Spiegel and the European Investigative Collaborations (EIC) network of journalists, begun publishing various articles relateding to various dirty deals relating to various dodgy deals behind Arab oil owned football clubs Manchester City, PSG, and Russian owned Monaco. Super League plans by current European powerhouses. Questionable dealings of football agents, Doping involving Russian and Spanish players. 2023 Brazilian football match-fixing scandal 2025 Turkish football betting scandal Age fraud in association football 2026 Manchester City F.C. financial breaches scandal: the club is found guilty on 114 of 115 charges from the initial leaks.

Clark Oderth Olofsson (later known as Daniel Demuynck; 1 February 1947 – 24 June 2025) was a Swedish criminal. He received sentences for attempted murder, assault, robbery and dealing narcotics and spent more than half of his life in prison. Olofsson was often referred to as Sweden's first "celebrity gangster". Olofsson faced a tumultuous childhood marked by familial challenges. Growing up amidst extensive alcohol problems, he endured the departure of his father and his mother's subsequent illness, which led to the placement of Olofsson and his two younger sisters in foster care. Determined to escape an unhappy foster family, Olofsson enrolled in a sailors' school then forged his mother's signature at the age of 15 to be able to embark on the ship Ballade, he sailed around the world, gaining a unique perspective between Japan and South America. Returning home at 15, Olofsson reunited with his mother, who had regained stability. Despite earlier adversities, the family settled in Gothenburg, where Olofsson's journey took a criminal turn. Convicted for various offenses in the 1960s, including burglary and assault, Olofsson gained notoriety for his involvement in the killing of a police officer during a robbery. Multiple prison escapes characterized his criminal career, with notable incidents like the Norrmalmstorg robbery, giving rise to the term "Stockholm syndrome". Throughout the 1970s and 1980s, Olofsson continued a pattern of escapes, criminal activities, and imprisonments, marked by a marriage in Kumla Prison.

Morpholino nucleic acids replace the sugar with a morpholine component, and the phosphate with a phosphorodiamidate component. Miravirsen is an antisense drug candidate that incorporates both locked nucleic acid sugar components and phosphorothioate groups.

Sources: en.wikipedia.org

Background from the literature

=== Effects on antigenicity of milk proteins === A study in 2012 posed the question of whether or not Lactobacillus delbrueckii subsp. bulgaricus had any effect on the antigenicity of four kinds of milk proteins, being α-lactalbumin (α-LA), β-lactoglobulin (β-LG), α-casein (α-CN), and β-casein (β-CN). These proteins are the main proteins found in cow's milk and are known to have antigenic properties in humans, especially young children and infants. 2–5% of young children and infants experience cow's milk protein allergy (CMPA), which has harmful effects on their development and may even result in death. This allergy is facilitated through the antigenicity of the milk proteins, which is the ability of the proteins to trigger an immune response in the body that can result in a number of possible allergic reactions. The study was performed by simulating digestion of unfermented milk and milk that was fermented through exposure to Lactobacillus delbrueckii subsp. bulgaricus to compare their antigenicities in order to see if fermentation had any effect on the antigenicity of the proteins. The antigenicities were measured through an enzyme-linked immunosorbent assay (ELISA). The results claimed that the fermentation of cow's milk by Lactobacillus delbrueckii subsp. bulgaricus reduced the antigenicity of α-LA and β-CN. However, it also increased the antigenicity of α-CN while β-LG was not impacted.

After his release from jail, Colonel Rhodes immediately joined his brother Cecil and the British South Africa Company in the Second Matabele War taking place just north of the Transvaal in Matabeleland. Cecil Rhodes was forced to resign as Prime Minister of Cape Colony in 1896 due to his apparent involvement in planning and assisting in the raid; he also, along with Alfred Beit, resigned as a director of the British South Africa Company. Jameson's raid had depleted Matabeleland of many of its troops and left the whole territory vulnerable. Seizing on this weakness, and a discontent with the British South Africa Company, the Ndebele revolted during March 1896 in what is now celebrated in Zimbabwe as the First War of Independence, the First Chimurenga, but it is better known to most of the world as the Second Matabele War. The Shona joined them soon thereafter. Hundreds of European settlers were killed within the first few weeks of the revolt and many more would die over the next year and a half. With few troops to support them, the settlers had to quickly build a laager in the centre of Bulawayo on their own. Against over 50,000 Ndebele held up in their stronghold of the Matobo Hills the settlers mounted patrols under such people as Burnham, Baden-Powell, and Selous. It would not be until October 1897 that the Ndebele and Shona would finally lay down their arms.

=== Weather === Some evidence suggests sunnier climates do not predict happiness. In one study, both Californians and Midwesterners expected the former's happiness ratings to be higher due to a sunnier environment. In fact, the Californian and Midwestern happiness ratings did not show a significant difference. Other research has found that temperature, wind power, sunlight, precipitation and air temperature has a small impact on mood, but some people appear to be affected in a large way (but it's not 5 factor personality). A study of Dutch teenagers identified that the effect of weather on mood depends on whether they were Summer lovers, summer haters, rain haters and unaffected by weather. Other researchers say the necessary minimum daily dose of sunlight is as little as 30 minutes. That is not to say weather is never a factor for happiness. Perhaps the changing norms of sunlight cause seasonal affective disorder, which undermines level of happiness.

Sources: en.wikipedia.org

Further detail

February 2: Decree establishing an agricultural action committee in every rural municipality and cantonal agricultural organization committees; women managing such farms have the right to vote in these committees. December 27: Law increasing penalties for specific forms of vagrancy; this notably concerns procuring. 1917

=== Nordic countries === Norway was the first country in the world to outlaw beak trimming in 1974, followed by Finland in 1986 and Sweden in 1988. Beak trimming was subsequently phased out in Denmark in two stages: in 2013 for the enriched cage system and in 2014 for aviary and free range systems.

is the half-life, E the total kinetic energy (of the alpha particle and the daughter nucleus), and A and B are coefficients that depend on the isotope's atomic number Z. The law works best for nuclei with even atomic number and even atomic mass. The trend is still there for even-odd, odd-even, and odd-odd nuclei but is not as pronounced.

Radioactive decay (also known as nuclear decay, radioactivity, radioactive disintegration, or nuclear disintegration) is the process by which an unstable atomic nucleus loses energy by radiation. A material containing unstable nuclei is considered radioactive. Three of the most common types of decay are alpha, beta, and gamma decay. The weak force is the mechanism that is responsible for beta decay, while the other two are governed by the electromagnetic and nuclear forces. Radioactive decay is a random process at the level of single atoms. According to quantum theory, it is impossible to predict when a particular atom will decay, regardless of how long the atom has existed. However, for a significant number of identical atoms, the overall decay rate can be expressed as a decay constant or as a half-life. The half-lives of radioactive isotopes have a huge range: from nearly instantaneous to far longer than the age of the universe. The decaying nucleus is called the parent radionuclide (or parent radioisotope), and the process produces at least one daughter nuclide. Except for gamma decay or internal conversion from a nuclear excited state, the decay is a nuclear transmutation resulting in a daughter containing a different number of protons or neutrons (or both). When the number of protons changes, an atom of a different chemical element is created. There are 28 naturally occurring chemical elements on Earth that are radioactive, consisting of 35 radionuclides (seven elements have two different radionuclides each) that date before the time of formation of the Solar System.

Sources: en.wikipedia.org

Frequently asked questions

How long does the albumin-binding form remain active?

Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.

What do researchers measure after administering the peptide?

Typical endpoints include growth hormone pulse frequency and amplitude, together with insulin-like growth factor 1 concentration. Some protocols add body composition or metabolic markers. Interpretation depends on baseline hormonal status, which varies widely between individuals.

Are the clinical effects well established?

Most human data come from small, early-stage studies, and independent replication is limited. Short-term effects on growth hormone release are documented; longer-term outcomes are not well characterized. Open questions include changes in pituitary responsiveness after repeated exposure.

Which receptor does the compound target?

It acts on the growth hormone-releasing hormone receptor found on pituitary somatotroph cells. Activation of that receptor triggers growth hormone release through a cyclic AMP dependent pathway.

Network